Research Article: Fractional Exhalation Nitric Oxide (FeNO) changes in cystic fibrosis patients induced by compound honey syrup: a pretest–posttest clinical trial
Abstract:
To evaluate the effect of Persian medicine Syrup ‘compound honey syrup (CHS)’ on fractional exhalation nitric oxide (FENO) changes in patients with cystic fibrosis (CF).
Introduction:
CF is a chronic and progressive genetic disease that, as a multisystem disease, affects not only the lungs, but also the pancreas, liver, and digestive system [1]. CF is the most common fatal genetic disorder in white people. This disease occurs in 1 in 2000 to 1 in 3500 births [2]. With the advent of new treatments, the average expected survival in patients has increased dramatically from about 8 years for patients born in the 1960s to about 46 years for patients born in 2017 [3]. Cystic fibrosis is an autosomal…
Read more